Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | AZN | AMGN | GILD | VRTX |
| Company | Intra-Cellular Ther | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 131.90 | 67.14 | 277.04 | 104.74 | 492.23 |
| High | 131.98 | 68.15 | 278.68 | 105.75 | 492.23 |
| Low | 131.63 | 67.09 | 268.50 | 103.52 | 485.08 |
| Last | 131.87 | 67.59 | 277.29 | 104.54 | 489.10 |
| Change | -0.05 | +0.54 | -5.35 | -0.34 | +3.21 |
| % Change | -0.04% | +0.81% | -1.89% | -0.32% | +0.66% |
| Volume | 16,062,900 | 3,796,000 | 4,371,800 | 8,066,700 | 1,205,400 |
| 20-Day Average Volume | 2,474,570 | 6,838,035 | 3,652,070 | 10,367,190 | 1,743,965 |
| Previous Close | 131.92 | 67.05 | 282.64 | 104.88 | 485.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 70.06 | 298.08 | 107.47 | 489.57 |
| 20-Day Raw Stochastic | 86.25% | 43.32% | 19.71% | 41.42% | 62.22% |
| 20-Day Relative Strength | 82.75% | 41.61% | 39.07% | 45.91% | 51.67% |
| Weighted Alpha | +83.21 | -6.96 | -3.84 | +54.05 | +20.05 |
| Today's Opinion | 100% Buy | 72% Sell | 56% Sell | 40% Buy | 64% Buy |
| Previous Opinion | 100% Buy | 56% Sell | 56% Sell | 40% Buy | 48% Buy |
| Last Month's Opinion | 100% Buy | 56% Buy | 56% Buy | 80% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | +4.19% since 04/10/25 | -1.46% since 04/10/25 | +3.10% since 04/10/25 | +2.86% since 04/10/25 |
| Low | 131.63 on 04/01/25 | 64.44 on 04/11/25 | 268.50 on 04/17/25 | 100.76 on 04/11/25 | 468.30 on 04/11/25 |
| High | 131.98 on 04/01/25 | 68.40 on 04/15/25 | 296.17 on 04/15/25 | 107.18 on 04/14/25 | 502.22 on 04/16/25 |
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | -12.64% since 03/17/25 | -12.57% since 03/17/25 | -6.88% since 03/17/25 | -4.80% since 03/17/25 |
| Low | 131.18 on 03/05/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 97.32 on 04/09/25 | 448.14 on 04/07/25 |
| High | 131.98 on 04/01/25 | 77.52 on 03/18/25 | 319.31 on 03/18/25 | 114.75 on 04/03/25 | 516.50 on 03/18/25 |
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | +1.49% since 01/17/25 | +1.90% since 01/17/25 | +13.83% since 01/17/25 | +15.90% since 01/17/25 |
| Low | 80.82 on 01/07/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 91.84 on 01/22/25 | 423.49 on 01/21/25 |
| High | 131.98 on 04/01/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | -13.37% since 10/17/24 | -13.71% since 10/17/24 | +19.67% since 10/17/24 | -1.93% since 10/17/24 |
| Low | 70.90 on 10/07/24 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 85.60 on 10/22/24 | 377.85 on 12/19/24 |
| High | 131.98 on 04/01/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 209,611,056 | 149,085,248 | 130,169,344 | 125,595,992 |
| Shares Outstanding, K | 106,522 | 3,101,214 | 537,651 | 1,245,163 | 256,790 |
| Annual Sales | 680,850,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -74,680,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 199,220,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -16,890,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 0.46 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/06/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.31 | 14.26 | 22.75 | 0.00 |